Tetralogy of Fallot

← Back to Index (πŸ’— Cardiology)

Introduction and Etiology

Anatomical Components and Pathophysiology

Clinical Manifestations

Hypercyanotic (Tet) Spells

Physical Examination

Diagnostic Investigations

Electrocardiogram (ECG)

Chest Radiograph (CXR)

Transthoracic Echocardiography

Cardiac Catheterization and Angiography

Management

Treatment of Hypercyanotic (Tet) Spells

Surgical and Transcatheter Interventions

Intervention Type Procedure Details Clinical Indications
Medical Stabilization Prostaglandin E1 (PGE1) Infusion (0.01 - 0.1 mcg/kg/min) Required in ductal-dependent neonates presenting with severe RVOTO or pulmonary atresia to maintain ductal patency and guarantee pulmonary blood flow until surgery.
Surgical Palliation Modified Blalock-Taussig-Thomas (BTT) Shunt A systemic-to-pulmonary shunt using a Gore-Tex/PTFE graft to connect the subclavian artery to the ipsilateral branch pulmonary artery. Reserved for premature/low-birth-weight infants or those with severely hypoplastic pulmonary arteries unfit for neonatal repair.
Transcatheter Palliation RVOT Stenting or Balloon Valvuloplasty Deployment of a stent across the stenotic RVOT to relieve cyanosis and promote somatic and pulmonary arterial growth. Serves as a bridge to surgery for high-risk neonates, though it destroys native pulmonary valve function.
Definitive Repair Intracardiac Repair (VSD Closure + RVOT Reconstruction) Open heart surgery under cardiopulmonary bypass. Involves patch closure of the VSD and relief of RVOTO via infundibular muscle resection and pulmonary valvotomy. If the pulmonary annulus is severely hypoplastic, a transannular patch is placed. Ideally performed electively between 3 and 6 months of age.

Postoperative Complications and Long-Term Follow-up